1. Gascoyne RD, Campo E, Jaffe ES, et al. Diffuse large B-cell lymphoma, NOS. In: WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. 4th ed. Swerdlow SH, Campo E, Harris
NL, et al., Eds. IARC, Lyon, 2017: 291-297.
2. Cigudosa JC, Parsa NZ, Louie DC, et al. Cytogenetic analysis of
363 consecutively ascertained diffuse large B-cell lymphomas.
Genes Chromosomes Cancer 25: 123-133, 1999.
3. Zhao X, Fan R, Lin G, Wang X. Chromosome abnormalities in
diffuse large B-cell lymphomas: analysis of 231 Chinese patients.
Hematol Oncol 31: 127-135, 2013.
4. Van Dyke DL. +18 or trisomy 18 in lymphoproliferative disorders.
Atlas Genet Cytogenet Oncol Haematol 7: 274-276, 2003.
5. Mitelman F, Johansson B, Mertens F, Eds. Mitelman database of
chromosome aberrations and gene fusions in cancer (2022) [Internet]. [cited 2022 Feb 8]. Available from: http://mitelmandatabase.is
b-cgc.org
6. Sanchez ML, Almeida J, Gonzalez D, et al. Incidence and clinicobiologic characteristics of leukemic B-cell chronic lymphoproliferative disorders with more than one B-cell clone. Blood 102:
2994-3002, 2003.
7. Sanchez ML, Almeida J, Lopez A, et al. Heterogeneity of neoplastic cells in B-cell chronic lymphoproliferative disorders: biclonality versus intraclonal evolution of a single tumor cell clone. Haematologica 91: 331-339, 2006.
8. Fend F, Quintanilla-Martinez L, Kumar S, et al. Composite low
grade B-cell lymphomas with two immunophenotypically distinct
cell populations are true biclonal lymphomas. Am J Pathol 154:
1857-1866, 1999.
9. Sklar J, Cleary ML, Thielemans K, Gralow J, Warnke R, Levy R.
Biclonal B-cell lymphoma. N Engl J Med 311: 20-27, 1984.
10. Finch CN, Nichols M, Shrimpton A, Liu D, Hutchison RE. Primary nodal marginal zone B-cell lymphoma arising from more
than one clonal neoplastic population. Arch Pathol Lab Med 124:
1816-1819, 2000.
11. Chang H, Cerny J. Molecular characterization of chronic lymphocytic leukemia with two distinct cell populations. Am J Clin Pathol 126: 23-28, 2006.
12. Delville JP, Heimann P, Housni HE, et al. Biclonal low grade Bcell lymphoma confirmed by both flow cytometry and karyotypic
analysis, in spite of a normal kappa/lambda Ig light chain ratio.
Am J Hematol 82: 473-480, 2007.
13. Ankathil R, Geetha N, Remani P, Gangadharan VP, Pillai GR,
Nair MK. Clinical implications of cytogenetic classification in
adult acute lymphoblastic leukaemia patients. J Cancer Res Clin
Oncol 122: 370-373, 1996.
14. Wada M, Okamura T, Okada M, et al. Frequent chromosome arm
13q deletion in aggressive non-Hodgkin’s lymphoma. Leukemia
291
Intern Med 62: 285-292, 2023
DOI: 10.2169/internalmedicine.9711-22
13: 792-798, 1999.
15. Wong KF, Chan JKC. Follicular lymphoma with trisomy 18 and
over-expression of BCL2 in the absence of t(14;18)(q32;q21). Cancer Genet Cytogenet 123: 52-54, 2000.
16. Viardot A, Martin-Subero JI, Siebert R, et al. Detection of secondary genetic aberrations in follicle center cell derived lymphomas:
assessment of the reliability of comparative genomic hybridization
and standard chromosome analysis. Leukemia 15: 177-183, 2001.
17. Dierlamm J, Pittaluga S, Wlodarska I, et al. Marginal zone B-cell
lymphomas of different sites share similar cytogenetic and morphologic features. Blood 87: 299-307, 1996.
18. Troussard X, Mauvieux L, Radford-Weiss I, et al. Genetic analysis
of splenic lymphoma with villous lymphocytes: a Groupe Français
d’Hématologie Cellulaire (GFHC) study. Br J Haematol 101: 712721, 1998.
19. Remstein ED, Law M, Mollejo M, Piris MA, Kurtin PJ, Dogan A.
The prevalence of IG translocations and 7q32 deletions in splenic
marginal zone lymphoma. Leukemia 22: 1268-1272, 2008.
20. Vinatzer U, Gollinger M, Müllauer M, Raderer M, Chott A,
Streubel B. Mucosa-associated lymphoid tissue lymphoma: novel
translocations including rearrangements of ODZ2, JMJD2C, and
CNN3. Clin Cancer Res 14: 6426-6431, 2008.
21. Sunohara M, Hara K, Osamura K, et al. Mucosa associated lymphoid tissue (MALT) lymphoma of the thymus with trisomy 18.
Intern Med 48: 2025-2032, 2009.
22. Ishikawa H, Iwamuro M, Okuda H, et al. Recurrence after radiotherapy for gastric mucosa-associated lymphoid tissue (MALT)
lymphoma with trisomy 18. Intern Med 54: 911-916, 2015.
23. Takimoto T, Maegawa S, Tatsumi H, et al. Extranodal marginal
zone lymphoma of the uterine cervix with concomitant copy number gains of the MALT1 and BCL2 genes: a case report. Oncol
Lett 13: 3641-3645, 2017.
24. Matsueda K, Omote S, Sakata M, Fujita I, Horii J, Toyokawa T.
The diagnosis of gastric mucosa-associated lymphoid tissue lymphoma by flow cytometry and fluorescence in situ hybridization of
biopsy specimens. Intern Med 57: 1081-1086, 2018.
25. Okamoto N, Hayashi E, Tsukino M. Pleural mucosa-associated
lymphoid tissue lymphoma with trisomy 18. Intern Med 58: 891892, 2019.
26. Nakamura S, Ye H, Bacon CM, et al. Clinical impact of genetic
aberrations in gastric MALT lymphoma: a comprehensive analysis
using interphase fluorescence in situ hybridisation. Gut 56: 13581363, 2007.
27. Sugimoto K, Imai H, Shimada A, et al. Diffuse large B-cell lymphoma of the uterus suspected of having transformed from a marginal zone B-cell lymphoma harboring trisomy 18: a case report
and review of the literature. Int J Clin Exp Pathol 6: 2979-2988,
2013.
28. Dierlamm J, Penas EMM, Bentink S, et al. Gain of chromosome
region 18q21 including the MALT1 gene is associated with the activated B-cell-like gene expression subtype and increased BCL2
gene dosage and protein expression in diffuse large B-cell lymphoma. Haematologica 93: 688-696, 2008.
29. van Dongen JJM, Hooijkaas H, Michiels JJ, et al. Richter’s syndrome with different immunoglobulin light chains and different
heavy chain gene rearrangements. Blood 64: 571-575, 1984.
The Internal Medicine is an Open Access journal distributed under the Creative
Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To
view the details of this license, please visit (https://creativecommons.org/licenses/
by-nc-nd/4.0/).
Ⓒ 2023 The Japanese Society of Internal Medicine
Intern Med 62: 285-292, 2023
292
...
論文の公開元へ
